Alterations in Rev-ERBα/BMAL1 ratio and glycated hemoglobin in rotating shift workers: the EuRhythDia study
Acta Diabetologica, vol. 58, pp. 1111–1117
Abstract
OBJECTIVE: To detect premature gluco-metabolic defects among night shift workers with disturbances in circadian rhythms. DESIGN AND METHODS: We performed a hypothesis-generating, cross-sectional analysis of anthropometric, metabolic, lipid, and inflammation parameters, comparing active (a-NSW, n = 111) and former (f-NSW, n = 98) rotating night shift workers with diurnal workers (controls, n = 69). All participants were hospital nurses. We also evaluated the Pittsburgh Sleep Quality Index (PSQI) and assessed expression of transcription factors REV-ERBα and BMAL1 in peripheral blood mononuclear cells (PBMCs), as indicators of the molecular clock. RESULTS: Both a-NSW and f-NSW participants had significantly higher glycated hemoglobin (HbA1c) and white blood cell counts (WBC) (p < 0.001 for both), PSQI global score (p = 0.001) and diastolic blood pressure levels (p = 0.024) compared with controls. Expression of REV-ERBα/BMAL1 RNA in PBMC was significantly higher in a-NSW (p = 0.05) than in f-NSW or control participants. Multivariate regression analysis showed that working status and PSQI were independent determinants of higher HbA1c levels (p < 0.001). CONCLUSIONS: We demonstrated that young, healthy night shift workers show subclinical abnormalities in HbA1c and changes in peripheral clock gene expression.
Authors 15
-
University of Rome Tor Vergata
Affiliation as printed
Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier, 100133, Rome, Italy
-
University of Rome Tor Vergata
Affiliation as printed
Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier, 100133, Rome, Italy
-
University of Rome Tor Vergata
Affiliation as printed
Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier, 100133, Rome, Italy
-
University of Rome Tor Vergata
Affiliation as printed
Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier, 100133, Rome, Italy
-
University of Rome Tor Vergata
Affiliation as printed
Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier, 100133, Rome, Italy
-
University of Rome Tor Vergata
Affiliation as printed
Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy
-
University of Rome Tor Vergata
Affiliation as printed
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
-
University Medical Center Hamburg-Eppendorf
Affiliation as printed
Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
-
University of Rome Tor Vergata
Affiliation as printed
Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier, 100133, Rome, Italy
-
Affiliation as printed
Department of Cardiology, University Medical Center Aachen, Aachen, Germany
-
Inserm · Université de Lille · Centre Hospitalier Universitaire de Lille · Institut Pasteur de Lille · Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires
Affiliation as printed
Univ. Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France
-
Affiliation as printed
Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, England
-
University Medical Center Hamburg-Eppendorf
Affiliation as printed
Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
-
Affiliation as printed
Department of Cardiology, University Medical Center Aachen, Aachen, Germany
-
Massimo Federici corresponding
University of Rome Tor Vergata
Affiliation as printed
Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier, 100133, Rome, Italy. federicm@uniroma2.it
Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier, 100133, Rome, Italy
Cited by 31 stored of 31
No patents citing this paper on Lens.org (checked 2026-10-06).